Published in Ann Plast Surg on March 01, 2015
Foreign body reaction to biomaterials. Semin Immunol (2007) 8.32
Fibronectin regulates Wnt7a signaling and satellite cell expansion. Cell Stem Cell (2013) 2.31
Skeletal muscle tissue engineering. J Cell Mol Med (2004) 1.63
ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr Opin Genet Dev (2013) 1.49
Molecular regulation of satellite cell function. Semin Cell Dev Biol (2005) 1.29
Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin Cell Dev Biol (2005) 1.24
Functional development of engineered skeletal muscle from adult and neonatal rats. Tissue Eng (2001) 1.18
Volumetric muscle loss. J Am Acad Orthop Surg (2011) 1.17
A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med (2006) 1.15
The fate of myoblasts following transplantation into mature muscle. Exp Cell Res (1995) 1.15
A murine model of volumetric muscle loss and a regenerative medicine approach for tissue replacement. Tissue Eng Part A (2012) 1.13
Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle (2005) 1.10
Tissue engineering of skeletal muscle using polymer fiber arrays. Tissue Eng (2003) 1.04
Satellite cell proliferation and skeletal muscle hypertrophy. Appl Physiol Nutr Metab (2006) 1.02
The role of fibroblasts in self-assembled skeletal muscle. Tissue Eng Part A (2011) 0.87
Scaffold-free tissue engineering: organization of the tissue cytoskeleton and its effects on tissue shape. Ann Biomed Eng (2014) 0.84
Focused in vivo genetic analysis of implanted engineered myofascial constructs. J Invest Surg (2009) 0.79
A model system for primary abdominal closures. Methods Mol Biol (2013) 0.79
Self-assembly of prevascular tissues from endothelial and fibroblast cells under scaffold-free, nonadherent conditions. Tissue Eng Part A (2014) 0.79
A model of tissue-engineered ventral hernia repair. J Invest Surg (2006) 0.78
Organ printing: tissue spheroids as building blocks. Biomaterials (2009) 2.43
An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res (2006) 2.14
VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood (2004) 1.81
Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol (2004) 1.75
Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood (2006) 1.48
Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol (2006) 1.45
Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol (2008) 1.38
A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol (2003) 1.27
Fibulin-1 is required for morphogenesis of neural crest-derived structures. Dev Biol (2008) 1.26
Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood (2003) 1.23
Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.18
Hematopoietic origin of glomerular mesangial cells. Blood (2002) 1.17
Hematopoietic origins of fibroblasts: I. In vivo studies of fibroblasts associated with solid tumors. Exp Hematol (2006) 1.15
A three-dimensional model of vasculogenesis. Biomaterials (2008) 1.09
Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn (2009) 1.07
Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation. BMC Dev Biol (2006) 1.06
Tissue engineering of skeletal muscle. Tissue Eng (2007) 1.06
Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem (2004) 1.05
Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci (2003) 1.04
Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. Proc Am Thorac Soc (2008) 1.02
Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol (2004) 1.00
Maxillofacial injuries and life-threatening hemorrhage: treatment with transcatheter arterial embolization. J Trauma (2003) 0.99
Patterning of embryonic blood vessels. Dev Dyn (2003) 0.99
Laparoscopic repair of large incisional hernias. Am Surg (2002) 0.93
Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process. J Mol Cell Cardiol (2011) 0.93
Epicardial development in the rat: a new perspective. Microsc Microanal (2006) 0.93
VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Dev Dyn (2002) 0.93
Microtensile testing of collagen fibril for cardiovascular tissue engineering. J Biomed Mater Res A (2005) 0.92
Vasculogenesis drives pulmonary vascular growth in the developing chick embryo. Dev Dyn (2005) 0.92
Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves. Dev Biol (2012) 0.91
The connexin43 carboxyl-terminal peptide ACT1 modulates the biological response to silicone implants. Plast Reconstr Surg (2009) 0.90
Circulating blood island-derived cells contribute to vasculogenesis in the embryo proper. Dev Biol (2003) 0.90
The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold. Biomaterials (2008) 0.89
Critical role for retinol in the generation/differentiation of angioblasts required for embryonic blood vessel formation. Dev Dyn (2004) 0.89
Diabetes insipidus in the head-injured patient. Am Surg (2004) 0.89
Adult reserve stem cells and their potential for tissue engineering. Cell Biochem Biophys (2004) 0.88
An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A (2010) 0.88
What is the future of diabetic wound care? Diabetes Educ (2006) 0.86
Fusion of uniluminal vascular spheroids: a model for assembly of blood vessels. Dev Dyn (2010) 0.86
A three-dimensional tubular scaffold that modulates the osteogenic and vasculogenic differentiation of rat bone marrow stromal cells. Tissue Eng Part A (2008) 0.86
VEGF-mediated phosphorylation of eNOS regulates angioblast and embryonic endothelial cell proliferation. Dev Biol (2012) 0.86
Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development. Ann Biomed Eng (2009) 0.85
Use of a vacuum-assisted device to facilitate abdominal closure. Am Surg (2003) 0.85
VEGF directs newly gastrulated mesoderm to the endothelial lineage. Dev Biol (2005) 0.85
3D printing facilitated scaffold-free tissue unit fabrication. Biofabrication (2014) 0.85
Coronary endothelial proliferation and morphogenesis are regulated by a VEGF-mediated pathway. Dev Dyn (2009) 0.85
VEGF-mediated fusion in the generation of uniluminal vascular spheroids. Dev Dyn (2008) 0.85
Three-dimensional model system of valvulogenesis. Dev Dyn (2005) 0.84
Scaffold-free tissue engineering: organization of the tissue cytoskeleton and its effects on tissue shape. Ann Biomed Eng (2014) 0.84
Biomedical implant capsule formation: lessons learned and the road ahead. Ann Plast Surg (2014) 0.82
A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration. Biomaterials (2010) 0.81
Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in engrafted mice. Pancreas (2008) 0.80
Focused in vivo genetic analysis of implanted engineered myofascial constructs. J Invest Surg (2009) 0.79
Self-assembly of prevascular tissues from endothelial and fibroblast cells under scaffold-free, nonadherent conditions. Tissue Eng Part A (2014) 0.79
Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues. Tissue Eng Part B Rev (2014) 0.78
Effects of platelet-derived growth factor-AA and -BB on embryonic cardiac development. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.78
A model of tissue-engineered ventral hernia repair. J Invest Surg (2006) 0.78
A 3-D model of coronary vessel development. In Vitro Cell Dev Biol Anim (2007) 0.78
Massive ventral hernia with extensive heterotopic ossification: the honeycomb-abdomen. J Trauma (2009) 0.77
Cocaine induced acidosis in the trauma patient: a potential confounding factor. Am Surg (2008) 0.77
Granulocyte/macrophage origin of glomerular mesangial cells. Int J Hematol (2005) 0.76
Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol (2004) 0.76
Nanomechanical characterization of micro/nanofiber reinforced type I collagens. J Biomed Mater Res A (2007) 0.76
Human satellite progenitor cells for use in myofascial repair: isolation and characterization. Ann Plast Surg (2010) 0.76
Novel tissue engineered tubular heart tissue for in vitro pharmaceutical toxicity testing. Microsc Microanal (2007) 0.75
A biomechanical and morphologic analysis of capsule formation around implanted piezoelectric wafer active sensors in rats treated with cyclooxygenase-2 inhibition. Ann Plast Surg (2008) 0.75
Unique recalcutrant hernia repair: enterocutaneous fistula with complex ventral hernia. Am Surg (2008) 0.75
Novel bacterial immobilization compound effectively decreases bacterial counts in healthy volunteers. Am Surg (2010) 0.75
The use of prognostic indicators in the development of a statistical model predictive for adrenal insufficiency in trauma patients. Am Surg (2007) 0.75
Cardiovascular tissue engineering I. Perfusion bioreactors: a review. J Long Term Eff Med Implants (2006) 0.75